Rahul Kumar

机构：University of Pittsburgh, Changi General Hospital, Hindu Rao Hospital, SingHealth Duke-NUS Academic Medical Centre, Duke-NUS Medical School, Cancer Research Center, UPMC Hillman Cancer Center · ORCID：0000-0002-5092-4821

发表论文 119 篇 · 总被引 3950 次 · h-index 26

代表论文

• A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease (2024 · Hepatology International · 被引 33)
• Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial (2025 · Nature Medicine · 被引 13)
• Artificial Intelligence and Machine Learning Predicting Transarterial Chemoembolization Outcomes: A Systematic Review (2024 · Digestive Diseases and Sciences · 被引 10)
• Rotational Thromboelastometry Reduces the Need for Preemptive Transfusion in Cirrhosis: A Randomized Controlled Trial (NCT:05698134) (2024 · Journal of Clinical and Experimental Hepatology · 被引 10)
• Non‐selective beta‐blocker is associated with reduced mortality in critically ill patients with cirrhosis: A real‐world study (2024 · Alimentary Pharmacology & Therapeutics · 被引 10)
• Innovative mRNA Vaccine Approaches in Targeting Atherosclerosis: A New Era in Cardiovascular Therapy (2024 · Cureus · 被引 9)